Angie’s List losses continue to climb
In a Monday SEC filing, the company said it lost $43.2 million through the first nine months of 2011, pushing total losses since 2006 to $160.6 million. Angie’s List filed in August to go public.
Initial Public Offerings
Articles
ExactTarget preparing for another IPO attempt
ExactTarget Inc., which canceled plans for an initial public offering during the 2009 financial crisis, has hired JPMorgan Chase & Co. and Deutsche Bank AG to handle a new attempt, said sources familiar with the matter.
Angie’s List faces challenges in bid to go public
The company said in its initial public offering that it has lost money since its inception. But it still could be attractive to prospective investors, said a local lawyer who helps companies go public.
Angie’s List files for initial public offering
Consumer review provider Angie's List on Thursday filed the papers for an initial public offering of stock. The filing pegged the value of the offering at $75 million, though the Indianapolis-based company said that amount could change.
Weak market could derail Allison’s planned IPO
Indianapolis-based Allison Transmission in March said it planned to raise $750 million through a public stock sale, but the economic outlook has darkened since then.
Sources: Angie’s List picks adviser to handle planned August IPO
Angie’s List Inc., a website that provides consumer reviews of plumbers, electricians and other services, is preparing to file in August for an initial public offering, said two people with direct knowledge of the plans.
Ingredients in place for plethora of Hoosier IPOs
Some Indiana firms are adding management and board firepower—moves likely to help them win over investors should they move ahead with public offerings.
ExactTarget stays patient as riches from IPO await
CEO Scott Dorsey says remaining private in the short term allows the company to more easily exploit business opportunities on the horizon.
Endocyte’s potential enthralls investors
Shares of Endocyte Inc. have doubled since the company’s initial public offering in February—even though the common wisdom is it won’t see sales from its first cancer drug until 2014.
Trucking industry upswing may draw investors to Allison IPO
Allison Transmission is not a household name like Google or General Motors, but it won’t lack an audience for its planned $750 million initial public offering.
Remy International files plans for public offering
Pendleton-based manufacturer Remy International Inc., the former General Motors Co. unit that exited bankruptcy in 2007, has filed plans to raise up to $100 million through an initial public stock offering.
Allison Transmission files for $750M IPO
Allison Transmission Inc. is counting on upgrades to truck and bus fleets in countries like China and India for its future growth, the company revealed in a filing it made Friday to raise up to $750 million through an initial public offering.
IPO could help ease Allison Transmission’s debt
Allison Transmission Inc.'s enormous debt load is probably one factor driving the company to consider a public offering, an investment analyst said Monday morning.
Endocyte shares climb after IPO expectations cut
Shares of biotechnology company Endocyte Inc. rose in afternoon trading Friday, after the company slashed pricing expectations for its initial public offering.
Endocyte again changes terms of public offering
The West Lafayette-based biopharmaceutical company now is planning to offer at least 12.5 million shares, or 17 percent more than previously announced, but at a lower price of $6 each.
Endocyte prices IPO stock
The West Lafayette-based drug development firm intends to sell 6.15 million shares for $13 to $15 apiece. That would fetch $80 million to $92 million.
GM shares jump in return to Wall Street
General Motors' return to Wall Street was well received Thursday, as the company’s stock closed up 3.6 percent in its initial public offering.
Vera Bradley shares off to impressive start
Stock in the Fort Wayne-based company began trading Thursday morning at $16 but climbed as high as $23.90.
Vera Bradley set to go public
The Fort Wayne-based company is scheduled to begin trading as a public company Wednesday morning. The estimated offering price is $14 to $16 each, although a Morningstar analyst predicts the IPO could bring as much as $18 a share.
Endocyte’s $86M IPO plan a boon for Indiana, investors
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.